Shimadzu Launches Blood-Based Amyloid Mass Spectrometry Service in North America for Supporting Alzheimer's Disease Drug Discovery and Development
COLUMBIA, Md. (PRWEB) July 08, 2022 -- Shimadzu Scientific Instruments announces the successful commercialization of a new Amyloid Mass Spectrometry (MS)